Serapide, F.; Guastalegname, M.; Gullì, S.P.; Lionello, R.; Bruni, A.; Garofalo, E.; Longhini, F.; Trecarichi, E.M.; Russo, A.
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence. Antibiotics 2024, 13, 506.
https://doi.org/10.3390/antibiotics13060506
AMA Style
Serapide F, Guastalegname M, Gullì SP, Lionello R, Bruni A, Garofalo E, Longhini F, Trecarichi EM, Russo A.
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence. Antibiotics. 2024; 13(6):506.
https://doi.org/10.3390/antibiotics13060506
Chicago/Turabian Style
Serapide, Francesca, Maurizio Guastalegname, Sara Palma Gullì, Rosaria Lionello, Andrea Bruni, Eugenio Garofalo, Federico Longhini, Enrico Maria Trecarichi, and Alessandro Russo.
2024. "Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence" Antibiotics 13, no. 6: 506.
https://doi.org/10.3390/antibiotics13060506
APA Style
Serapide, F., Guastalegname, M., Gullì, S. P., Lionello, R., Bruni, A., Garofalo, E., Longhini, F., Trecarichi, E. M., & Russo, A.
(2024). Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence. Antibiotics, 13(6), 506.
https://doi.org/10.3390/antibiotics13060506
